Form 8-K - Current report:
SEC Accession No. 0001437749-24-034551
Filing Date
2024-11-12
Accepted
2024-11-12 16:11:57
Documents
16
Period of Report
2024-11-12
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K dyai20240905_8k.htm   iXBRL 8-K 27659
2 EXHIBIT 99.1 ex_721715.htm EX-99.1 170435
7 dyadic.jpg GRAPHIC 2007
  Complete submission text file 0001437749-24-034551.txt   350477

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA dyai-20241112.xsd EX-101.SCH 3410
4 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE dyai-20241112_def.xml EX-101.DEF 11425
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE dyai-20241112_lab.xml EX-101.LAB 15311
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE dyai-20241112_pre.xml EX-101.PRE 11585
18 EXTRACTED XBRL INSTANCE DOCUMENT dyai20240905_8k_htm.xml XML 2847
Mailing Address 1044 NORTH U.S. HIGHWAY ONE SUITE 201 JUPITER FL 33477
Business Address 1044 NORTH U.S. HIGHWAY ONE SUITE 201 JUPITER FL 33477 561-743-8333
DYADIC INTERNATIONAL INC (Filer) CIK: 0001213809 (see all company filings)

EIN.: 450486747 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-32513 | Film No.: 241448252
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)